Volitionrx (VNRX) Equity Average (2019 - 2025)
Historic Equity Average for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to -$34.5 million.
- Volitionrx's Equity Average fell 5162.73% to -$34.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.5 million, marking a year-over-year decrease of 5162.73%. This contributed to the annual value of -$17.4 million for FY2024, which is 19410.78% down from last year.
- As of Q3 2025, Volitionrx's Equity Average stood at -$34.5 million, which was down 5162.73% from -$31.1 million recorded in Q2 2025.
- Volitionrx's 5-year Equity Average high stood at $28.9 million for Q2 2021, and its period low was -$34.5 million during Q3 2025.
- Moreover, its 5-year median value for Equity Average was -$143567.0 (2022), whereas its average is -$3.0 million.
- Per our database at Business Quant, Volitionrx's Equity Average soared by 10782.62% in 2021 and then plummeted by 392722.46% in 2023.
- Volitionrx's Equity Average (Quarter) stood at $19.5 million in 2021, then plummeted by 100.74% to -$143567.0 in 2022, then plummeted by 3927.22% to -$5.8 million in 2023, then tumbled by 321.57% to -$24.4 million in 2024, then tumbled by 41.64% to -$34.5 million in 2025.
- Its last three reported values are -$34.5 million in Q3 2025, -$31.1 million for Q2 2025, and -$27.6 million during Q1 2025.